I'll explore how integrating a comprehensive AI-driven onboarding framework can provide a realistic, effective blueprint for ...

AML enforcement is now the top regulatory risk for crypto firms, CertiK reports. Global AML fines exceeded $900 million in H1 2025, led by OKX and KuCoin. SEC crypto penalties dropped 97% from 2024 as ...

Genomic profiling enables therapy individualization when actionable mutations (FLT3, NPM1, IDH1/2, TP53) are present, moving AML care beyond one-size-fits-all induction and transplant algorithms.

Preemptive azacitidine treatment guided by measurable residual disease (MRD) status was associated with delayed relapse in patients with myelodysplastic neoplasms or acute myeloid leukemia (AML), with ...

Menin inhibitors reshape AML care, boosting targeted options for KMT2A- and NPM1-mutant disease, with promising frontline combinations beyond relapsed settings. In an interview with Targeted Oncology, ...

New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations. For decades, the “7+3” strategy—comprising 7 days of continuous ...

This manuscript provides a single-cell transcriptomic atlas for AML (222 samples comprising 748,679 cells) integrating data from multiple studies. They use this dataset to investigate t(8;21) AML, and ...

Fidelity National Financial’s (FNF) legal battle with the Financial Crimes Enforcement Network (FinCEN) may soon be over, that is, if the court takes the recommendations of Magistrate Judge Samuel ...

(RTTNews) - Shares of SELLAS Life Sciences Group Inc. (SLS) are up nearly 7% at $1.86 in premarket trading, following promising clinical data from its ongoing Phase 2 study of SLS009 in ...